BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo GF, Cai YC, Zhang B, Xu RH, Qiu HJ, Xia LP, Jiang WQ, Hu PL, Chen XX, Zhou FF, Wang F. Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosis. Med Oncol 2011;28 Suppl 1:S197-203. [PMID: 21080109 DOI: 10.1007/s12032-010-9696-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Prasad S, Yadav VR, Sung B, Reuter S, Kannappan R, Deorukhkar A, Diagaradjane P, Wei C, Baladandayuthapani V, Krishnan S, Guha S, Aggarwal BB. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Clin Cancer Res. 2012;18:4942-4953. [PMID: 22832932 DOI: 10.1158/1078-0432.ccr-11-2805] [Cited by in Crossref: 103] [Cited by in F6Publishing: 52] [Article Influence: 10.3] [Reference Citation Analysis]
2 Zhang Y, Song M, Chen XF, Meng Y. Expression of adaptor protein containing PH domain, PTB domain and leucine zipper motif 1 in colorectal carcinogenesis. Shijie Huaren Xiaohua Zazhi 2012; 20(3): 253-258 [DOI: 10.11569/wcjd.v20.i3.253] [Reference Citation Analysis]
3 Huang CY, Kuo WT, Huang YC, Lee TC, Yu LC. Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells. Cell Death Dis. 2013;4:e622. [PMID: 23640464 DOI: 10.1038/cddis.2013.149] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 6.8] [Reference Citation Analysis]
4 Liu H, Ertay A, Peng P, Li J, Liu D, Xiong H, Zou Y, Qiu H, Hancock D, Yuan X, Huang WC, Ewing RM, Downward J, Wang Y. SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity. Mol Oncol 2019;13:1874-86. [PMID: 31199048 DOI: 10.1002/1878-0261.12530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
5 Huang CY, Yu LCH. Pathophysiological mechanisms of death resistance in colorectal carcinoma. World J Gastroenterol 2015; 21(41): 11777-11792 [PMID: 26557002 DOI: 10.3748/wjg.v21.i41.11777] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
6 Patra M, Johnstone TC, Suntharalingam K, Lippard SJ. A Potent Glucose-Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells. Angew Chem 2016;128:2596-600. [DOI: 10.1002/ange.201510551] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
7 Patra M, Johnstone TC, Suntharalingam K, Lippard SJ. A Potent Glucose-Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells. Angew Chem Int Ed Engl 2016;55:2550-4. [PMID: 26749149 DOI: 10.1002/anie.201510551] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 16.0] [Reference Citation Analysis]
8 Tsimihodimos V, Filippas-Ntekouan S, Elisaf M. SGLT1 inhibition: Pros and cons. Eur J Pharmacol 2018;838:153-6. [PMID: 30240793 DOI: 10.1016/j.ejphar.2018.09.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
9 Schweiger T, Hegedüs B, Nikolowsky C, Hegedüs Z, Szirtes I, Mair R, Birner P, Döme B, Lang G, Klepetko W, Ankersmit HJ, Hoetzenecker K. EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study. Ann Surg Oncol 2014;21:946-54. [PMID: 24281417 DOI: 10.1245/s10434-013-3386-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
10 Koepsell H. The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer. Pharmacology & Therapeutics 2017;170:148-65. [DOI: 10.1016/j.pharmthera.2016.10.017] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 10.4] [Reference Citation Analysis]
11 Li H, Wang K, Wan Q, Chen Y. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives. Steroids 2019;141:81-95. [DOI: 10.1016/j.steroids.2018.11.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
12 Chen CH, Wang BW, Hsiao YC, Wu CY, Cheng FJ, Hsia TC, Chen CY, Wang Y, Weihua Z, Chou RH, Tang CH, Chen YJ, Wei YL, Hsu JL, Tu CY, Hung MC, Huang WC. PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs. Oncogene 2021;40:4796-808. [PMID: 34155348 DOI: 10.1038/s41388-021-01889-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Martinez CA, Scafoglio C. Heterogeneity of Glucose Transport in Lung Cancer. Biomolecules 2020;10:E868. [PMID: 32517099 DOI: 10.3390/biom10060868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Kobayashi M, Uematsu T, Tokura Y, Takei K, Sakamoto K, Narimatsu T, Nukui A, Kamai T. Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications. Int Braz J Urol 2019;45:169-78. [PMID: 30521176 DOI: 10.1590/S1677-5538.IBJU.2018.0271] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 Mojica L, Luna-Vital DA, Gonzalez de Mejia E. Black bean peptides inhibit glucose uptake in Caco-2 adenocarcinoma cells by blocking the expression and translocation pathway of glucose transporters. Toxicol Rep 2018;5:552-60. [PMID: 29854625 DOI: 10.1016/j.toxrep.2018.04.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
16 Kania E, Pająk B, Orzechowski A. Calcium homeostasis and ER stress in control of autophagy in cancer cells. Biomed Res Int 2015;2015:352794. [PMID: 25821797 DOI: 10.1155/2015/352794] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 13.4] [Reference Citation Analysis]
17 Garcia C, Kubat JS, Fulton RS, Anthony AT, Combs M, Powell CB, Littell RD. Clinical outcomes and prognostic markers in uterine leiomyosarcoma: a population-based cohort. Int J Gynecol Cancer. 2015;25:622-628. [PMID: 25675041 DOI: 10.1097/igc.0000000000000370] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
18 Martins SF, Amorim R, Viana-Pereira M, Pinheiro C, Costa RF, Silva P, Couto C, Alves S, Fernandes S, Vilaça S, Falcão J, Marques H, Pardal F, Rodrigues M, Preto A, Reis RM, Longatto-Filho A, Baltazar F. Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis. BMC Cancer 2016;16:535. [PMID: 27460659 DOI: 10.1186/s12885-016-2566-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
19 Perez R, Crombet T, de Leon J, Moreno E. A view on EGFR-targeted therapies from the oncogene-addiction perspective. Front Pharmacol 2013;4:53. [PMID: 23637683 DOI: 10.3389/fphar.2013.00053] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
20 Huang CY, Huang CY, Pai YC, Lin BR, Lee TC, Liang PH, Yu LC. Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance. Front Oncol 2019;9:1282. [PMID: 31824857 DOI: 10.3389/fonc.2019.01282] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
21 Wang H, Peng R, Chen X, Jia R, Huang C, Huang Y, Xia L, Guo G. Effect of HK2, PKM2 and LDHA on Cetuximab efficacy in metastatic colorectal cancer. Oncol Lett 2018;15:5553-60. [PMID: 29552193 DOI: 10.3892/ol.2018.8005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Madunić IV, Madunić J, Breljak D, Karaica D, Sabolić I. Sodium-glucose cotransporters: new targets of cancer therapy? Arh Hig Rada Toksikol 2018;69:278-85. [PMID: 30864374 DOI: 10.2478/aiht-2018-69-3204] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
23 Chang CK, Chiu PF, Yang HY, Juang YP, Lai YH, Lin TS, Hsu LC, Yu LC, Liang PH. Targeting Colorectal Cancer with Conjugates of a Glucose Transporter Inhibitor and 5-Fluorouracil. J Med Chem 2021;64:4450-61. [PMID: 33819035 DOI: 10.1021/acs.jmedchem.0c00897] [Reference Citation Analysis]
24 Ren J, Bollu LR, Su F, Gao G, Xu L, Huang WC, Hung MC, Weihua Z. EGFR-SGLT1 interaction does not respond to EGFR modulators, but inhibition of SGLT1 sensitizes prostate cancer cells to EGFR tyrosine kinase inhibitors. Prostate 2013;73:1453-61. [PMID: 23765757 DOI: 10.1002/pros.22692] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
25 Hu Z, Xiao L, Bode AM, Dong Z, Cao Y. Glycolytic genes in cancer cells are more than glucose metabolic regulators. J Mol Med 2014;92:837-45. [DOI: 10.1007/s00109-014-1174-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
26 Gao HF, Chen LY, Cheng CS, Chen H, Meng ZQ, Chen Z. SLC5A1 promotes growth and proliferation of pancreatic carcinoma via glucose-dependent AMPK/mTOR signaling. Cancer Manag Res 2019;11:3171-85. [PMID: 31114359 DOI: 10.2147/CMAR.S195424] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
27 Wang J, Ji H, Niu X, Yin L, Wang Y, Gu Y, Li D, Zhang H, Lu M, Zhang F, Zhang Q. Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer. Dis Markers 2020;2020:6103542. [PMID: 32377271 DOI: 10.1155/2020/6103542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Zhu W, Li MC, Wang FR, Mackenzie GG, Oteiza PI. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling. Biochem Pharmacol 2020;175:113923. [PMID: 32217102 DOI: 10.1016/j.bcp.2020.113923] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
29 Patra M, Awuah SG, Lippard SJ. Chemical Approach to Positional Isomers of Glucose-Platinum Conjugates Reveals Specific Cancer Targeting through Glucose-Transporter-Mediated Uptake in Vitro and in Vivo. J Am Chem Soc 2016;138:12541-51. [PMID: 27570149 DOI: 10.1021/jacs.6b06937] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 13.2] [Reference Citation Analysis]
30 Karabulut M, Afsar CU, Alıs H, Oran E, Karabulut S, Akarsu C, Sahbaz NA, Gümüsoglu AY, Bilgin E, Aykan NF. Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer. Mol Clin Oncol 2017;7:787-97. [PMID: 29142750 DOI: 10.3892/mco.2017.1405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
31 Guo GF, Jiang WQ, Zhang B, Cai YC, Xu RH, Chen XX, Wang F, Xia LP. Autophagy-related proteins Beclin-1 and LC3 predict cetuximab efficacy in advanced colorectal cancer. World J Gastroenterol 2011; 17(43): 4779-4786 [PMID: 22147978 DOI: 10.3748/wjg.v17.i43.4779] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
32 Lai B, Xiao Y, Pu H, Cao Q, Jing H, Liu X. Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma. Arch Gynecol Obstet 2012;285:1455-61. [DOI: 10.1007/s00404-011-2166-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
33 Zeng N, Okumura T, Alauddin M, Khozooei S, Rajaxavier J, Zhang S, Singh Y, Shi B, Brucker SY, Wallwiener D, Takeda S, Lang F, Salker MS. LEFTY2/endometrial bleeding-associated factor up-regulates Na+ Coupled Glucose Transporter SGLT1 expression and Glycogen Accumulation in Endometrial Cancer Cells. PLoS One 2020;15:e0230044. [PMID: 32236143 DOI: 10.1371/journal.pone.0230044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Lin HW, Tseng CH. A Review on the Relationship between SGLT2 Inhibitors and Cancer. Int J Endocrinol 2014;2014:719578. [PMID: 25254045 DOI: 10.1155/2014/719578] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
35 Shi M, Wang C, Ji J, Cai Q, Zhao Q, Xi W, Zhang J. CRISPR/Cas9-mediated knockout of SGLT1 inhibits proliferation and alters metabolism of gastric cancer cells. Cell Signal 2021;90:110192. [PMID: 34774990 DOI: 10.1016/j.cellsig.2021.110192] [Reference Citation Analysis]
36 Seidensticker M, Ulrich G, Muehlberg FL, Pethe A, Grosser OS, Steffen IG, Stiebler M, Goldschmidt J, Smalla KH, Seidensticker R, Ricke J, Amthauer H, Mohnike K. Tumor Cell Uptake of 99mTc-Labeled 1-Thio-β-d-Glucose and 5-Thio-d-Glucose in Comparison with 2-Deoxy-2-[18 F]Fluoro-d-Glucose In Vitro: Kinetics, Dependencies, Blockage and Cell Compartment of Accumulation. Mol Imaging Biol 2014;16:189-98. [DOI: 10.1007/s11307-013-0690-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]